Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml.

Ewa Witkowska-PatenaAgnieszka GiżewskaMirosław DziukJolanta MiśkoAnna BudzyńskaAgata Walęcka-Mazur

Published in: Prostate cancer and prostatic diseases (2019)

18F-PSMA-1007 PET/CT shows relatively high detection rate in patients with PCa after radical treatment and low, rising PSA levels. Like other PSMA-targeting radiotracers, its detection rate is dependent on PSA levels. 18F-PSMA-1007 also presents excellent sensitivity, specificity and NPV.

Keyphrases

pet ct
prostate cancer
radical prostatectomy
positron emission tomography
acute lymphoblastic leukemia
loop mediated isothermal amplification
label free
computed tomography
cancer therapy
drug delivery
combination therapy